Literature DB >> 16304053

Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival.

Wojciech Swat1, Vivianne Montgrain, Teresa A Doggett, Jason Douangpanya, Kamal Puri, William Vermi, Thomas G Diacovo.   

Abstract

Class 1 phosphoinositide 3-kinases (PI3Ks), consisting of PI3Kalpha, beta, gamma, and delta, are a family of intracellular signaling molecules that play important roles in cell-mediated immune responses. In thymocytes, however, their role is less clear, although PI3Kgamma is postulated to partially contribute to pre-TCR-dependent differentiation. We now report that PI3Kdelta, in conjunction with PI3Kgamma, is required for thymocyte survival and ultimately for T-cell production. Surprisingly, genetic deletion of the p110delta and p110gamma catalytic subunits resulted in a dramatic reduction in thymus size, cellularity, and lack of corticomedullary differentiation. Total thymocyte counts in these animals were 27-fold lower than in wild-type (WT) controls because of a diminished number of CD4+ CD8+ double-positive (DP) cells and were associated with T-cell depletion in blood and in secondary lymphoid organs. Moreover, this alteration in the DP population was intrinsic to thymocytes, because the reconstitution of p110gammadelta-/- animals with WT fetal liver cells restored the proportions of all thymocyte populations to those in WT controls. The observed defects were related to massive apoptosis in the DP population; TCRB expression, pre-TCR selection, and generation of DP cells appeared relatively unperturbed. Thus, class 1 PI3Ks work in concert to protect developing thymocytes from apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16304053      PMCID: PMC1895732          DOI: 10.1182/blood-2005-08-3300

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

Review 1.  Glucocorticoids in T cell development and function*.

Authors:  J D Ashwell; F W Lu; M S Vacchio
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration.

Authors:  T Sasaki; J Irie-Sasaki; R G Jones; A J Oliveira-dos-Santos; W L Stanford; B Bolon; A Wakeham; A Itie; D Bouchard; I Kozieradzki; N Joza; T W Mak; P S Ohashi; A Suzuki; J M Penninger
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

3.  Immature thymocytes that fail to express TCRbeta and/or TCRgamma delta proteins die by apoptotic cell death in the CD44(-)CD25(-) (DN4) subset.

Authors:  I Falk; G Nerz; I Haidl; A Krotkova; K Eichmann
Journal:  Eur J Immunol       Date:  2001-11       Impact factor: 5.532

Review 4.  On the brink of becoming a T cell.

Authors:  Christine Borowski; Colin Martin; Fotini Gounari; Loralee Haughn; Iannis Aifantis; Fabio Grassi; Harald von Boehmer
Journal:  Curr Opin Immunol       Date:  2002-04       Impact factor: 7.486

Review 5.  Lymphostromal interactions in thymic development and function.

Authors:  G Anderson; E J Jenkinson
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

Review 6.  T-cell development and the CD4-CD8 lineage decision.

Authors:  Ronald N Germain
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

7.  Aggregation of the human high affinity immunoglobulin G receptor (FcgammaRI) activates both tyrosine kinase and G protein-coupled phosphoinositide 3-kinase isoforms.

Authors:  A J Melendez; D J Gillooly; M M Harnett; J M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

8.  Maturation versus death of developing double-positive thymocytes reflects competing effects on Bcl-2 expression and can be regulated by the intensity of CD28 costimulation.

Authors:  D J McKean; C J Huntoon; M P Bell; X Tai; S Sharrow; K E Hedin; A Conley; A Singer
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

Review 9.  Tec kinases: modulators of lymphocyte signaling and development.

Authors:  C M Lewis; C Broussard; M J Czar; P L Schwartzberg
Journal:  Curr Opin Immunol       Date:  2001-06       Impact factor: 7.486

10.  Vav1 transduces T cell receptor signals to the activation of phospholipase C-gamma1 via phosphoinositide 3-kinase-dependent and -independent pathways.

Authors:  Lucinda F Reynolds; Lesley A Smyth; Trisha Norton; Norman Freshney; Julian Downward; Dimitris Kioussis; Victor L J Tybulewicz
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

View more
  55 in total

Review 1.  A survival guide to early T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature.

Authors:  Evgeni Efimenko; Utpal P Davé; Irina V Lebedeva; Yao Shen; Maria J Sanchez-Quintero; Daniel Diolaiti; Andrew Kung; Brian J Lannutti; Jianchung Chen; Ronald Realubit; Zoya Niatsetskaya; Vadim Ten; Charles Karan; Xi Chen; Andrea Califano; Thomas G Diacovo
Journal:  Mol Cancer Ther       Date:  2017-07-17       Impact factor: 6.261

Review 3.  Lymphocyte cell motility: the twisting, turning tale of phosphoinositide 3-kinase.

Authors:  J S Oak; M P Matheu; I Parker; M D Cahalan; D A Fruman
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

Review 4.  Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond.

Authors:  David A Medina-Tato; Stephen G Ward; Malcolm L Watson
Journal:  Immunology       Date:  2007-08       Impact factor: 7.397

5.  p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease.

Authors:  Aurore Saudemont; Fabien Garçon; Hakim Yadi; Marta Roche-Molina; Nayoung Kim; Anne Segonds-Pichon; Alfonso Martín-Fontecha; Klaus Okkenhaug; Francesco Colucci
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

6.  Mitochondrial Pyruvate Carrier 1 Promotes Peripheral T Cell Homeostasis through Metabolic Regulation of Thymic Development.

Authors:  Andrew G Ramstead; Jared A Wallace; Soh-Hyun Lee; Kaylyn M Bauer; William W Tang; H Atakan Ekiz; Thomas E Lane; Ahmad A Cluntun; Matthew L Bettini; June L Round; Jared Rutter; Ryan M O'Connell
Journal:  Cell Rep       Date:  2020-03-03       Impact factor: 9.423

Review 7.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

8.  The role of the PI3K-AKT kinase pathway in T-cell development beyond the beta checkpoint.

Authors:  Ling Xue; Leslie Chiang; Chulho Kang; Astar Winoto
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

Review 9.  Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma.

Authors:  Jason R Westin
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-02-07

10.  Thymic development beyond beta-selection requires phosphatidylinositol 3-kinase activation by CXCR4.

Authors:  Michelle L Janas; Gabriele Varano; Kristjan Gudmundsson; Mamiko Noda; Takashi Nagasawa; Martin Turner
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.